← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

DocGo Inc. (DCGO) 10-Year Financial Performance & Capital Metrics

DCGO • • Industrial / General
HealthcareHealthcare FacilitiesHome Health & Hospice CareMobile Health & Transport Services
AboutDocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.Show more
  • Revenue $617M -1.2%
  • EBITDA $45M +41.6%
  • Net Income $20M +191.5%
  • EPS (Diluted) 0.18 +177.3%
  • Gross Margin 34.64% +10.7%
  • EBITDA Margin 7.23% +43.3%
  • Operating Margin 4.65% +93.0%
  • Net Margin 3.24% +195.2%
  • ROE 6.45% +174.5%
  • ROIC 7.48% +43.7%
  • Debt/Equity 0.18 +19.1%
  • Interest Coverage 13.24
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 66.4%
  • ✓Trading at only 0.3x book value
  • ✓Efficient asset utilization: 1.4x turnover

✗Weaknesses

  • ✗Weak momentum: RS Rating 8 (bottom 8%)
  • ✗Dividend payout exceeds 100% of earnings
  • ✗Thin 5Y average net margin of 0.9%
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y66.42%
3Y24.6%
TTM-47.03%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-5.57%
TTM-99999900%

EPS CAGR

10Y-
5Y-
3Y-10.37%
TTM-279.99%

ROCE

10Y Avg-1.55%
5Y Avg2.69%
3Y Avg7.23%
Latest8.77%

Peer Comparison

Mobile Health & Transport Services
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
DCGODocGo Inc.87.74M0.904.98-1.24%-153983.33%-217447.38%73.51%0.18

Profit & Loss

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+48.3M94.09M318.72M440.52M624.29M616.56M
Revenue Growth %-0.95%2.39%0.38%0.42%-0.01%
Cost of Goods Sold+35.11M62.74M208.97M285.79M428.91M402.98M
COGS % of Revenue0.73%0.67%0.66%0.65%0.69%0.65%
Gross Profit+13.19M31.35M109.75M154.72M195.38M213.57M
Gross Margin %0.27%0.33%0.34%0.35%0.31%0.35%
Gross Profit Growth %-1.38%2.5%0.41%0.26%0.09%
Operating Expenses+33.95M46.1M94.39M132.89M180.33M184.89M
OpEx % of Revenue0.7%0.49%0.3%0.3%0.29%0.3%
Selling, General & Admin28.55M39.41M83.56M116.94M153.04M157.41M
SG&A % of Revenue0.59%0.42%0.26%0.27%0.25%0.26%
Research & Development1.22M1.19M3.32M5.38M10.86M11.59M
R&D % of Revenue0.03%0.01%0.01%0.01%0.02%0.02%
Other Operating Expenses4.18M5.51M7.51M10.57M16.43M15.88M
Operating Income+-20.76M-14.76M15.36M21.83M15.05M28.69M
Operating Margin %-0.43%-0.16%0.05%0.05%0.02%0.05%
Operating Income Growth %-0.29%2.04%0.42%-0.31%0.91%
EBITDA+-16.58M-9.25M22.87M32.4M31.49M44.57M
EBITDA Margin %-0.34%-0.1%0.07%0.07%0.05%0.07%
EBITDA Growth %-0.44%3.47%0.42%-0.03%0.42%
D&A (Non-Cash Add-back)4.18M5.51M7.51M10.57M16.43M15.88M
EBIT-20.76M-14.76M20.56M21.83M15.05M29.68M
Net Interest Income+-545.87K-204.63K-763.03K762.68K1.68M-1.93M
Interest Income545.87K00762.68K1.68M236.95K
Interest Expense0204.63K763.03K002.17M
Other Income/Expense-428.28K125.91K4.44M950.26K1.24M-939.72K
Pretax Income+-21.19M-14.63M19.8M22.78M16.29M27.75M
Pretax Margin %-0.44%-0.16%0.06%0.05%0.03%0.05%
Income Tax+47.03K167.44K615.7K-7.96M6.24M14.39M
Effective Tax Rate %0.95%0.98%1.2%1.52%0.42%0.72%
Net Income+-20.21M-14.36M23.74M34.58M6.86M19.99M
Net Margin %-0.42%-0.15%0.07%0.08%0.01%0.03%
Net Income Growth %-0.29%2.65%0.46%-0.8%1.91%
Net Income (Continuing)-21.24M-14.8M19.18M30.74M10.05M13.36M
Discontinued Operations000000
Minority Interest10.89M11.95M7.48M5.7M4.38M-5.74M
EPS (Diluted)+-0.20-0.140.250.340.060.18
EPS Growth %-0.3%2.79%0.36%-0.81%1.77%
EPS (Basic)-0.20-0.140.300.340.070.20
Diluted Shares Outstanding100.22M100.22M94.86M102.98M105.62M109.42M
Basic Shares Outstanding100.22M100.22M80.29M101.23M103.51M102.4M
Dividend Payout Ratio-----64746.54%

Balance Sheet

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+59.14M58.42M256.03M271.08M338.87M304.49M
Cash & Short-Term Investments47.74M32.42M175.54M157.34M59.29M89.24M
Cash Only47.74M32.42M175.54M157.34M59.29M89.24M
Short-Term Investments000000
Accounts Receivable10.16M24.85M78.38M103M262.08M210.9M
Days Sales Outstanding76.896.4289.7785.34153.23124.85
Inventory0004.48M00
Days Inventory Outstanding---5.72--
Other Current Assets0106.27M17.5M4.34M
Total Non-Current Assets+41.82M41.75M53.57M122.2M151.58M151.13M
Property, Plant & Equipment20.41M21.1M26.24M39.37M38.42M42.18M
Fixed Asset Turnover2.37x4.46x12.15x11.19x16.25x14.62x
Goodwill6.31M6.61M8.69M38.9M47.54M47.43M
Intangible Assets9.97M10.67M10.68M22.97M37.68M25.73M
Long-Term Investments00589.06K597.98K553.57K5.55M
Other Non-Current Assets5.13M3.36M7.38M10.4M15.5M21.83M
Total Assets+100.96M100.17M309.6M393.28M490.45M455.62M
Asset Turnover0.48x0.94x1.03x1.12x1.27x1.35x
Asset Growth %--0.01%2.09%0.27%0.25%-0.07%
Total Current Liabilities+9.73M23.5M57.88M100.16M170.12M121.81M
Accounts Payable947.94K3.95M15.83M21.58M19.83M28.36M
Days Payables Outstanding9.852327.6627.5616.8725.68
Short-Term Debt564.91K664.36K626.33K664.91K25.03M30.01M
Deferred Revenue (Current)000000
Other Current Liabilities680.49K3.58M11.89M49.38M39.81M27.4M
Current Ratio6.08x2.49x4.42x2.71x1.99x2.50x
Quick Ratio6.08x2.49x4.42x2.66x1.99x2.50x
Cash Conversion Cycle---63.5--
Total Non-Current Liabilities+11.87M9.73M24.67M14.19M15.16M18.64M
Long-Term Debt751.5K594.49K1.3M1.24M41.59K5.21K
Capital Lease Obligations11.12M9.14M9.85M12.96M15.12M18.63M
Deferred Tax Liabilities000000
Other Non-Current Liabilities0013.52M000
Total Liabilities21.6M33.23M82.55M114.35M185.28M140.44M
Total Debt+15.54M13.89M16.51M19.91M46.5M57.19M
Net Debt-32.2M-18.53M-159.03M-137.42M-12.79M-32.05M
Debt / Equity0.20x0.21x0.07x0.07x0.15x0.18x
Debt / EBITDA--0.72x0.61x1.48x1.28x
Net Debt / EBITDA---6.95x-4.24x-0.41x-0.72x
Interest Coverage--72.12x20.13x--13.24x
Total Equity+79.36M66.95M227.06M278.93M305.17M315.18M
Equity Growth %--0.16%2.39%0.23%0.09%0.03%
Book Value per Share0.790.672.392.712.892.88
Total Shareholders' Equity68.47M55M219.58M273.23M300.79M320.92M
Common Stock0010.01K10.24K10.41K10.19K
Retained Earnings-72.94M-87.3M-63.56M-28.97M-21.39M-1.4M
Treasury Stock000000
Accumulated OCI-244.88K-48.54K-32.5K741.21K1.48M1.22M
Minority Interest10.89M11.95M7.48M5.7M4.38M-5.74M

Cash Flow

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-14.21M-10.65M-1.95M28.87M-64.22M70.34M
Operating CF Margin %-0.29%-0.11%-0.01%0.07%-0.1%0.11%
Operating CF Growth %-0.25%0.82%15.82%-3.22%2.1%
Net Income-21.24M-14.8M19.18M30.74M6.86M19.99M
Depreciation & Amortization4.18M5.51M7.07M10.57M16.43M15.88M
Stock-Based Compensation457.47K687.07K1.38M8.05M20.97M13.63M
Deferred Taxes2.47M1.85M-630.38K-9.96M-1.98M3.47M
Other Non-Cash Items147.51K-300K-142.67K2.64M6.62M-2.16M
Working Capital Changes-224.22K-3.61M-28.8M-13.18M-113.12M19.52M
Change in Receivables-2.28M-16.15M-58M-8.42M-160.52M41.27M
Change in Inventory000000
Change in Payables-100.67K3.01M11.88M3.64M-1.78M8.56M
Cash from Investing+-2.97M-6.04M-8.59M-38.45M-29.88M-10.87M
Capital Expenditures-1.45M-4.36M-4.81M-3.2M-7.58M-3.83M
CapEx % of Revenue0.03%0.05%0.02%0.01%0.01%0.01%
Acquisitions------
Investments------
Other Investing-1.19M-3.45M-1.82M-2.3M-2.84M-1.73M
Cash from Financing+56.34M-812.09K155.21M-6.18M1.12M-24.15M
Debt Issued (Net)------
Equity Issued (Net)------
Dividends Paid00000-1.29T
Share Repurchases------
Other Financing10.5M1.47M-19.6M1.49M-21.17M1.29T
Net Change in Cash------
Free Cash Flow+-18.01M-16.97M-8.6M23.37M-74.35M64.5M
FCF Margin %-0.37%-0.18%-0.03%0.05%-0.12%0.1%
FCF Growth %-0.06%0.49%3.72%-4.18%1.87%
FCF per Share-0.18-0.17-0.090.23-0.700.59
FCF Conversion (FCF/Net Income)0.70x0.74x-0.08x0.83x-9.36x3.52x
Interest Paid1.07M1.05M840.75K756.6K850.34K2.91M
Taxes Paid47.03K117.44K615.7K1.51M4.25M7.25M

Key Ratios

Metric201920202021202220232024
Return on Equity (ROE)-25.47%-19.63%16.15%13.67%2.35%6.45%
Return on Invested Capital (ROIC)-33.02%-23.16%19.78%15.63%5.2%7.48%
Gross Margin27.31%33.32%34.43%35.12%31.3%34.64%
Net Margin-41.84%-15.26%7.45%7.85%1.1%3.24%
Debt / Equity0.20x0.21x0.07x0.07x0.15x0.18x
Interest Coverage--72.12x20.13x--13.24x
FCF Conversion0.70x0.74x-0.08x0.83x-9.36x3.52x
Revenue Growth-94.81%238.74%38.21%41.72%-1.24%

Revenue by Segment

202120232024
Mobile Health Services-442.79M423.13M
Mobile Health Services Growth---4.44%
Transportation Services-181.5M193.43M
Transportation Services Growth--6.58%
Majors Service Lines Member318.72M--
Majors Service Lines Member Growth---

Revenue by Geography

202120232024
UNITED STATES-571.89M558.79M
UNITED STATES Growth---2.29%
UNITED KINGDOM-52.4M57.76M
UNITED KINGDOM Growth--10.24%
PrimaryGeographicalMarketsMember318.72M--
PrimaryGeographicalMarketsMember Growth---

Frequently Asked Questions

Valuation & Price

DocGo Inc. (DCGO) has a price-to-earnings (P/E) ratio of 5.0x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

DocGo Inc. (DCGO) reported $368.1M in revenue for fiscal year 2024. This represents a 662% increase from $48.3M in 2019.

DocGo Inc. (DCGO) saw revenue decline by 1.2% over the past year.

DocGo Inc. (DCGO) reported a net loss of $56.68T for fiscal year 2024.

Dividend & Returns

Yes, DocGo Inc. (DCGO) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.

DocGo Inc. (DCGO) has a return on equity (ROE) of 6.4%. This is below average, suggesting room for improvement.

DocGo Inc. (DCGO) generated $51.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.